title: [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
authors.forename: María
authors.initials: M
authors.lastname: Castellanos González
authors.forename: Mercedes
authors.initials: M
authors.lastname: Pérez Carreras
authors.forename: Raquel
authors.initials: R
authors.lastname: Muñoz Gómez
authors.forename: Gregorio
authors.initials: G
authors.lastname: Castellano Tortajada
mesh_terms: D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003646:Debridement; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009336:Necrosis; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012883:Skin Ulcer / Q000139:chemically induced* / Q000188:drug therapy / Q000601:surgery
chemical_list: D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D019980:Amoxicillin-Potassium Clavulanate Combination; C417083:peginterferon alfa-2b